| Tag | Content |
|---|
EnhancerAtlas ID | HS191-02490 |
Organism | Homo sapiens |
Tissue/cell | Trophoblast |
Coordinate | chr1:161581940-161583190 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr1:161582764-161582782 | CCTCCCTTCCTTCCTTTG | - | 6.66 | | EWSR1-FLI1 | MA0149.1 | chr1:161582760-161582778 | CTTTCCTCCCTTCCTTCC | - | 9.01 | | KLF5 | MA0599.1 | chr1:161582351-161582361 | GGGGCGGGGC | - | 6.02 | | ZNF263 | MA0528.1 | chr1:161582760-161582781 | CTTTCCTCCCTTCCTTCCTTT | - | 6.12 | | ZNF263 | MA0528.1 | chr1:161582205-161582226 | TGAGGAGTGCGGGGGGGAAGA | + | 6.2 |
|
| | Number of super-enhancer constituents: 14 | ID | Coordinate | Tissue/cell |
| SE_07357 | chr1:161580788-161584698 | Brain_Hippocampus_Middle_150 | | SE_09867 | chr1:161579384-161583530 | CD14 | | SE_12235 | chr1:161581303-161583400 | CD3 | | SE_12654 | chr1:161581792-161582273 | CD34_adult | | SE_12771 | chr1:161581912-161582301 | CD34_fetal | | SE_12771 | chr1:161582578-161582932 | CD34_fetal | | SE_13494 | chr1:161579645-161584358 | CD34_Primary_RO01536 | | SE_15335 | chr1:161579226-161584686 | CD4_Memory_Primary_7pool | | SE_16693 | chr1:161581295-161583416 | CD4_Naive_Primary_8pool | | SE_20036 | chr1:161580924-161584169 | CD56 | | SE_20740 | chr1:161577990-161584457 | CD8_Memory_7pool | | SE_22436 | chr1:161580812-161584433 | CD8_primiary | | SE_39938 | chr1:161580902-161584380 | K562 | | SE_53727 | chr1:161580858-161583334 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 161582451 | 161582780 | | chr1 | 161582212 | 161582506 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I161611 | chr1 | 161580791 | 161583390 |
|
Enhancer Sequence | TTGTCGCAAA GCGGGAAAAA TGAAACAGCC TCCGACAGCT CTTTCCTCTT TCCTCACTAC 60
CCAAACTAAA CCTTAAGGCT CCATTTTCCC TGGCGACTCT TCGAGCGCCC CTCTGCTTCT 120
GTAGAGGGGT CGAGCCATGT CAAGGTAGAC CCTGTGTCGG CCCGTCTCCC TCGGATCCTC 180
CGCACCAATC ACTGTTGCTG AATCCGACAC CCGGCGGATC CAGTGCGGAG TCTCGAACAG 240
CTGCGGAGCT GGGAGCTACG GGACATGAGG AGTGCGGGGG GGAAGAGAAG ACGGCGGAGG 300
AAAATCCCCC GGCGGTGCTC AACTGCGGCT TTCTCTCTCG GCTGTGAGCC GGCTCCGCCC 360
TCCGGCTTCC AGAGCAAGTG GCTTCTGCGT TCACCGCCCC CCGCCGTTTG TGGGGCGGGG 420
CCGATTCATA AGAATCGGTT CTCACCAATG GAGGGCTTAG CATGTTTAAC CTCAGGATCA 480
TAAACAAAAG ACACTGCTAG AACGGTCGGG AAAGTCATAC GCTTTGCTTA TCTTATATAT 540
AGATTTCTAA AATTCCAAAC CGGGGACGCG TTGGTGGTGT AGTGGTGAGC ACAGCTGCCT 600
TTCAAGCAGT TAACGCGGGT TCGATTCCCG GGTAACGAAA CGTTTTTGTC TTTCCTTCTA 660
CGAAAAACTT TTCTGAGCCG GAGCCTCCAG CGCGCTGTGT ATTCGTTTTA CGCCTCAACG 720
AAACTGCAGC AATACCTCAC TTTCCGTACT CGCTTCCTGT CTTTCCCCTG GCCTCTTTCT 780
AAACCCAGGC TTTTTTTGAA GGGATTAAAT TCTGATGGTT CTTTCCTCCC TTCCTTCCTT 840
TGTAAACTTC CAACTCTTGA GGAATCTTTG GGATCATTTC AATCCTGGGA TGAGTCTTAG 900
CTTCAGAAAG GGGCTCTTGT GTCTTCACTT GCGAGGTTCA TTCGCTAGCC TCTACAAATC 960
ATCACTTAAG CCCCTAATTA TTCCCGGCCG AGGTCCTAGG CTAAGGTCCC GGGCCAAGCT 1020
TTCTAATTAG TCCCAGGCCA AGGTCCCAGG CCAACCTAAA TCACGCATTC TCCAAAACAG 1080
CCGGCAAACT AAGCACATTC CTTCCCGTTT CCAGTCCATA AACCCCCCCC CCCAAGTGGC 1140
CTCATAGTAA GCAACTCATT CGGGCCCCCT CTCTGCTGGC AAAAAGCTCA GATGTACTGG 1200
ACTGTGCATT TGATTTGGAA CTGAGTTACA TGGGAGAGAA GCAGGGATTC 1250
|
